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Abstract
There are few diagnostic tools for chronic musculoskeletal pain as structural imaging methods seldom reveal pathological
alterations. This is especially true for Whiplash Associated Disorder, for which physical signs of persistent injuries to the neck
have yet to be established. Here, we sought to visualize inflammatory processes in the neck region by means Positron
Emission Tomography using the tracer
11C-D-deprenyl, a potential marker for inflammation. Twenty-two patients with
enduring pain after a rear impact car accident (Whiplash Associated Disorder grade II) and 14 healthy controls were
investigated. Patients displayed significantly elevated tracer uptake in the neck, particularly in regions around the spineous
process of the second cervical vertebra. This suggests that whiplash patients have signs of local persistent peripheral tissue
inflammation, which may potentially serve as a diagnostic biomarker. The present investigation demonstrates that painful
processes in the periphery can be objectively visualized and quantified with PET and that
11C-D-deprenyl is a promising
tracer for these purposes.
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Introduction
Chronic musculoskeletal pain syndromes are common, cause
extensive individual suffering and place a large burden on health care
in society. Yet, pain remains notoriously difficult to visualize and
diagnose objectively. Furthermore the pathophysiology of persistent
pain is elusive and there is a great need for ways to visualize and
quantify pain mechanisms. One common chronic pain syndrome is
Whiplash Associated Disorder (WAD), where the onset is a soft tissue
sprain of the neck caused by a rear end motor vehicle collision or a
similar trauma. The injury is usually benign [1] and resolves within a
couple of months, but in a sub-portion of the population, whiplash
injuries proceed to chronic debilitating pain. Generally accepted
diagnostic criteria for WAD exist [2], but the etiology of chronic
symptoms is not known [3], and there is a lack of an objective
biomarker for chronic WAD [4]. Recent magnetic resonance
imaging (MRI) studies of the neck in WAD have indicated structural
abnormalities in the deep cervical muscles and ligaments, typically
around the uppermost vertebras [5,6]. However, such findings can
also be present in healthy subjects, and thus largely fail to distinguish
between WAD and normal, pain-free natural variations [6].
Furthermore, structural imaging does not capture on-going biological
processes; where as molecular imaging with positron emission
tomography (PET) has the potential to visualize such mechanisms.
One candidate PET tracer for musculoskeletal injuries and
inflammation is C
11 (S-(+)-(d)-D-deprenyl, or DDE). High DDE
retention has been demonstrated in the synovium in arthritic knee
joints [7]. This suggests that DDE can be used to visualize chronic
inflammatory processes even though the specific binding mechanism
of the tracer is not yet known. The present study explores if DDE
retention is elevated in the neck region in chronic WAD patients as
compared to pain free controls. We hypothesized that WAD patients
would have an elevated DDE retention in deep neck muscle regions.
Materials and Methods
Participants
Twenty-two patients (female/male: 18/4, mean age 6SD
36612 years) with chronic neck pain after car accident involving
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12 of the patients experienced a rear end collision, 5 patients
experienced combined lateral and frontal collisions. Detailed
collision descriptions were not available from 5 patients. All
patients were diagnosed with whiplash associated disorder (WAD)
grade II [2] and had experienced persistent pain between 6 and 24
months post trauma. The average time (6S.D.) since injury was
1567 months. Specific exclusion criteria for patients were loss of
consciousness at the time of the car accident, neurological
symptoms, WAD due to other accidents than by car, and pain
not related to WAD. The patient group was largely identical to
that described in our recent brain imaging studies [3,4]. All
patients reported neck pain, limited range of neck movement and
frequent headaches.
Fourteen healthy control subjects were also investigated.
Control group A consisted of eight healthy and pain free
volunteers (all females, mean age 3369 years) recruited through
advertisements. Control group B consisted of six patients with
acute musculoskeletal pain (sprained ankle), but otherwise healthy
and without current or prior neck pain (female/male: 3/3, mean
age 36614 years). General exclusion criteria for patients and
controls were psychiatric disorder, somatic disease, substance
abuse and pregnancy. The study was approved by the local ethical
review board (Regionala Etikpro ¨vningsna ¨mnden i Uppsala,
approval Ups 02-124) and the local radiation protection
committee (Uppsala University Hospital, Sweden). All participants
provided written informed consent before entering the study.
Subjective ratings
Prior to the PET investigation, participants rated their pain
intensity on a 0-100 visual analogue pain scale (VAS), and
completed the state portion of the Spielberger State Trait Anxiety
Inventory (STAI-s) [5]. Patients were also administered the Neck
Disability Index (NDI) [6,7] and a whiplash questionnaire [2,8]
with accident description, health prior to whiplash injury and
current symptom ratings. Pain localization drawings were
obtained form all patients, but they were not detailed enough to
asses the exact location of the neck pain, All participants refrained
from analgesics and anti-inflammatory drugs one to three days
(depending on drug half-life), from tobacco, alcohol and caffeine
12 h, and from food 3 h prior to the PET investigation.
PET investigation
Carbon-11 marked DDE was produced for each PET
investigation at GE healthcare, Uppsala Imanet following
published procedures [9]. WAD patients were examined with
DDE using an ECAT EXACT HR+ PET scanner (Siemens/CTI,
Knoxville, USA). The scanner enabled acquisition of 63
contiguous planes of data with a distance of 2.46 mm resulting
in a total axial field of view of 15.5 cm. Subjects were supine on
the scanner couch with the head and neck comfortably and gently
fixated, and positioned with the scanner field of view originating
approximately 2 cm above the orbitomeatal line, allowing for 3D
dynamical PET data acquisition from the base of the occipital
bone down to the shoulder region. A 10 min transmission scan
was performed using three retractable Germanium-68 rotating
line sources. Thereafter, the patients received an intravenous bolus
injection of DDE in the arm, approximately 5 MBq/kg body
weight (mean dose 6SD =330662 MBq). Simultaneously, a
45 min dynamic emission scan (3D mode) was initiated comprising
of twelve frames: 4630 s, 3660 s, 26300 s, and 36600 s. These
emission scans were reconstructed with a filter back projection
using a 4 mm Hanning filter, resulting in a spatial resolution of
about 5 mm in the field of view.
During the course of the study, a new PET-CT (GE discovery
ST, General Electric Medical Systems, Milwaukee, WI) was
installed and control subjects were investigated on this scanner,
allowing for fusion of PET and CT images giving higher
confidence in anatomical definitions. As different scanners were
used for patients and controls, three of the 22 WAD patients were
first investigated in the PET scanner and then also reinvestigated
in the PET-CT scanner in order to ensure reproducibility across
the two scanners. The time between these two investigations was
about one month.
Control group A (8 healthy, pain free volunteers) was
investigated on the PET-CT scanner, which has 24 rings of
bismuth germinate crystal detectors. This scanner enabled the
acquisition of 47 contiguous planes of data with a distance of
3.27 mm, resulting in a total axial field of view of 15.7 cm [10].
Positioning of the subjects was the same as for the patients. The
PET-CT investigation was initiated with a short CT scan (140kV;
auto mA 10–80 mA; pitch 1.75; speed 35) for attenuation
correction of the PET emission data. After this procedure, the
DDE (mean dose 6SD=371612 MBq) was administered as an
intravenous bolus in the arm of the subject. As for the patient
group, a 45 min dynamic emission scan (3D mode) was initiated
with the same frame sequence. PET data was reconstructed using
the OSEM (Ordered Subset Expectation Maximization) algorithm
with 2 iterations and 32 subsets and with a Gaussian postproces-
sing filter 5.14 mm in width. All PET data were corrected for
decay, photon attenuation, scatter, random coincidences and dead
time. Control group B (6 subjects with acute ankle sprain) was
investigated by means of a single 10 minute static image collected
over the cervical neck region approximately 50 min post injection,
DDE dose (424658 MBq). Image reconstruction and post
processing was identical to control group A.
Image analysis
Images were first analyzed visually and locations of elevated
tracer retention were specified with guidance from anatomical
atlases and CT images when available. To quantify DDE
retention, a series of regions of interest (ROIs) were defined in
each subject. ROIs of identical size and shape were delineated in
(I) a sphere in the non glandular regions with the most elevated
retention, (called peak ROI), (II) a sphere left or right of the
spineous process of axis (henceforth called right C2 ROI and left
C2 ROI), (III) a sphere in the spongeus bone of the cervical
vertebra 2 through 6 (vertebra ROIs), and (IV) a larger prolate
spheroid in muscle tissue region without visually evident elevated
retention (muscle ROI), see table 1 for a summary of ROI
definitions. The ROIs were positioned in the last acquisition frame
of the PET data in order to reflect specific uptake rather than
blood flow. For each ROI and each time point, the radioactivity
concentrations was extracted and recalculated with respect to the
administered dose of radioactivity and the subject’s body weight to
represent standardized uptake values (SUV) [11] using an image
analysis program (Amide Medical Image Data Examiner version
0.9.1) [12]. Plots of mean DDE SUV over time for each ROI in
each subject, called time activity curves (TAC) were generated for
subjects where dynamical PET data was available (patients and
control group A). To test for differences in ROI uptake between
patients and controls, two sided students T-test were performed on
the SUV values from the last acquisition frame, 45 to 50 minutes
post tracer injection.
Test reproducibility evaluation
Three patients were imaged with both the Siemens HR+ PET
and the GE discovery PET-CT system. Reproducibility across
Chronic Pain Imaging Using DDE
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the SUV TAC data at the 12 time points for the above
specified ROIs from each subject in both PET scans. In
addition, two more peak ROIs were generated for the regions
with the second and third highest tracer uptake in each patient.
As a metric of test reproducibility, the Pearson product moment
coefficient of determination was calculated for SUV values at all
time point from the HR+ and the PET-CT system in each
patient for each ROI. See Figure S1 for comparisons of PET
and PET-CT.
Results
Several soft tissue regions displayed visually evident elevated
tracer retention in WAD patients, see figure 1. In both patients
and controls, the uptake rate of DDE appeared stable 30 minutes
post injection. Control group A and B did not differ significantly
(p.0.3) on any of the ROI retention measures, therefore, to
improve statistical power, ROI data from the two control groups
was collapsed into one group for subsequent comparisons with the
patient group.
Table 1. Region of Interest (ROI) definitions.
ROI Volume (mm
3) Shape Position/definition
Peak 500 Sphere Non glandular soft tissue with highest uptake
Right C2 4200 Sphere Region right of spineous process of C2
Left C2 4200 Sphere Region left of spineous process of C2
Vertebra 500 Sphere Spongeous bone of C2 through C6
Muscle 6300 Prolate spheroid Muscle region without high uptake
doi:10.1371/journal.pone.0019182.t001
Figure 1. DDE uptake in a representative healthy control (left) and a whiplash patient (right). The patient displays high DDE uptake in
the adipose tissue right of the spineous process of C2. PET images are overlaid on the subject’s individual CT anatomy and tracer uptake is expressed
as standardized uptake values.
doi:10.1371/journal.pone.0019182.g001
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controls in tissue regions adjacent to spineous process of the second
vertebra (right C2 ROI p=0.008, left C2 ROI p=0.015), in the
normal muscle tissue (p=0.027) and in the peak soft tissue ROI
(p=0.035), but similar levels in the in the spongeus bone of the
cervical vertebra (p=0.48) see table 2 and figure 2.
Peak retentions were located around the spineous process of C2
in most patients, and also at the insertion of rectus capitis posterior
major in the occipital bone, see table 3. In the control group,
retention in the fat between the sternocleidomastoid muscle and
the levator scapulae muscle was the most common finding. In the
three patients investigated with combined PET and CT, the
location of the peak DDE retention was in the fat tissue
surrounding the muscle, see figure 1.
Ratings
Patients reported significantly elevated VAS neck pain ratings
(patients (n=22) mean 6SD=47621, control group A (n=8) =
468, p,0.001). Control group B (n=6) reported pain due to their
acutely sprained ankle pain at rest (VAS=23620, p,0.05), but
no neck pain. Patient’s ratings of neck disabilities (NDI) were also
significantly elevated (patients (n=22) mean 6SD=1865,
controls (n=8) =261). No differences were found with respect
to ratings of anxiety (STAI-s) at the time of investigation (patients
(n=22) mean 6SD =3167, controls (n=8) =3065). Within the
patient group, VAS pain ratings displayed a trend towards a
positive correlation with DDE uptake in the C2 ROI (r=0.39,
p=0.065).
Test reproducibility across scanners
The test reproducibility between the two PET scanners used
was high in all ROIs for the three subjects investigated on both
scanners. The lowest observed coefficient of determination (r
2)
between the first and the second scan in SUV measures of the
vertebra and muscle tissue was r
2 $0.74 (p,0.001). In the
presumably abnormal soft tissue peak ROIs, r
2 was $0.63
(p,0.001). In the right and left C2 ROI’s the lowest observed r
2
was $0.93 (p,0.001) and r
2 $0.86 (p,0.001) respectively. See
also Figure S1.
General tracer characteristics
DDE displayed high retention in the submandibular and the
parotid glands, and in the spongeous bone of the vertebra in all
Table 2. Standardizes Uptake Values (SUV) for DDE retention
in regions of interest.
ROI Patients SUV (±SD) Controls SUV (±SD) t-test p value
Peak 2.7360.95 1.9661.16 0.035
Right C2 1.5260.55 1.0560.41 0.0082
Left C2 1.5960.69 1.0860.42 0.015
Vertebra 2.2260.52 2.0960.56 0.48
Muscle 0.9860.23 0.7960.28 0.027
doi:10.1371/journal.pone.0019182.t002
Figure 2. DDE uptake over time at the second cervical vertebra.
Mean time activity curve indicated in standardized uptake values of
DDE in two spherical regions of interest (ROI) left and right of the
spineous process of C2. Bars indicate standard error. The area under the
curve was significantly higher for patients (n=22) than controls (n=8)
both in the right (p,0.004) and left (p,0.021) ROIs.
doi:10.1371/journal.pone.0019182.g002
Table 3. Non glandular soft tissue with the most elevated D-
Deprenyl uptake in patients.
Subject Location of Peak DDE retention SUV
Patient 5 Left semispinalis cervicis muscle at C2 5.08
Patient 1 Left oblicus capitis inferior muscle 3.92
Patient 4 Right rectus capitis posterior major 3.81
Patient 10 Left insertion of rectus capitis posterior
major in occipital bone
3.73
Patient 20 Left fat between sternocleidomatstoid
and levator scapulae
3.66
Patient 12 Left semispinalis cervicis at C2 3.44
Patient 16 Nuchal ligament at axis 3.42
Patient 13 Left insertion of rectus capitis posterior
major in occipital bone
3.38
Patient 22 Right fat between semispinalis capitis and C3 2.94
Patient 6 Left semispinalis cervicis muscle at C7 2.71
Patient 14 Left semispinalis cervicis at C2 2.49
Patient 21 Right fat at upper insertion of rectus
capitis posterior major
2.32
Patient 8 Left levator scapulae at C4 2.13
Patient 2 Right oblicuus capitis inferior/semispinalis
capitis at C2
2.07
Patient 7 Right multifidus muscle at C2 2.06
Patient 18 Right semispinalis at C6 2.06
Patient 3 Right rectus capitis posterior major 2.02
Patient 15 Splenius capitis muscle at C5 1.97
Patient 9 Left sternocleidomastoid muscle at C1 1.94
Patient 19 Left semispinalis at occipital insertion 1.90
Patient 11 Right insertion of sternocleidomastoideus
in occipital bone
1.54
Patient 17 Right sternocleidomastoid muscle 1.36
SUV Standardized Uptake Value, anatomical locations are approximate,
corresponding to the nearest identifiable region and may refer to surrounding
tissue.
doi:10.1371/journal.pone.0019182.t003
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retention during the early frames, but this decreased rapidly,
characteristic of high blood flow without specific binding. In the
cerebellum, the retention of the radioligand was moderate and
non-specific. Muscle displayed generally low tracer retention
(figure 3).
Discussion
Patients displayed elevated DDE retention in cervical soft tissue,
suggesting that localized chronic inflammation is apparent in
around 50% of grade II whiplash associated disorder patients.
From the PET-CT data, the site of tracer retention appeared to be
localized to adipose tissue surrounding deep cervical muscles. The
time activity curves (TAC) from the dynamic PET-data show a
rapid increase in the first frames followed by a plateau in the last
frames as with specific binding or trapping of the tracer. In regions
with high blood flow, such as the carotid artery (figure 3), there was
no retention of the tracer, suggesting that the elevated uptake in
patients was not due to enhanced perfusion in affected areas. The
trend towards a positive correlation between tracer retention and
subjective pain ratings also suggests that DDE has may indicate the
presence of painful inflammatory processes. Structural MRI
studies indicate that WAD patients have high fatty infiltration in
the cervical muscles [13], and an autopsy study suggest an increase
in type IIC muscle fibers in the neck flexor muscles of patients with
chronic neck pain [14]. Also, impairments in intramuscular
microcirculation have been demonstrated in painful muscles [15].
Along with inflammation, these alterations in the microstructure
and tissue composition of cervical tissue in WAD patients are
possible mechanisms which could lead to elevated [
11C]D-
deprenyl retention. The tracer retention observed in fatty regions
surrounding deep cervical muscle may indicate that adipose tissue
is actively involved in the inflammatory process [16]. If DDE
uptake can differentiate between traumatic and non-traumatic
neck pain remains to be investigated.
The main limitation of this study is that we do not yet know the
exact mechanism of the increased DDE uptake. (S-(+)-(d)-D-
deprenyl is the mirror isomer of L-deprenyl, a well established
MAO B inhibitor also known as selegeline [17]. However, the
mirror isomer DDE is 20 to 500 times less potent as an MAO-B
inhibitor than L-deprenyl [17]. L-deprenyl administration does
not block DDE retention in inflammatory tissue, but corticosteroid
injections does [18], suggesting that DDE may mark inflammation
independent of MAO-B binding. There is some evidence
suggesting that deprenyl has cytoprotective and antiapoptotic
properties [19,20,21], effects that are possibly mediated either
through an adaptive increase in superoxide dismutase activity
[22,23] or increased cell-cell adhesion [24]. Thus, further studies
are needed to elucidate the exact retention mechanism of DDE
and its role in inflammation. The present study is also limited by
the use of two different PET scanners. However, the reproduc-
ibility across scanners was sufficient both normal tissue and regions
with elevated tracer retention, supporting the validity of the
observed group differences. Another possible limitation is that
when [
18F] fluorodeoxyglucose (FDG) PET is used to detect
tumors, an uptake somewhat resembling the current finding has
been observed in patients who are cold [25,26]. The FDG uptake
has been attributed to sympathetic noradrenergic outflow, leading
to elevated metabolism in regions with brown adipose tissue. In the
present study, all subjects fasted at least 3 h prior to the
examinations, and were indoors in a centrally heated environment
kept at 21uC for at least one hour prior to tracer administration.
Both these procedures serve to reduce or eliminate brown fat
metabolic activity [27].
This study represents a phase 1 diagnostic study [28] and
further studies are needed before DDE PET can be recommended
as a test in clinical practice [29]. Evaluating the specificity of the
uptake against detailed clinical investigations of pain presentation,
comparisons between DDE and other radioligands (i.e. FDG [30]),
a more detailed anatomical resolution (through PET-CT or PET-
MRI) and control groups including non-traumatic neck pain and
headache patients are warranted.
Conclusions
The present investigation demonstrates that painful processes in
the periphery can be objectively visualized and quantified with
Figure 3. Tracer characteristics. Time activity curve in standardized uptake values are indicated for the C2 ROI, the cerebellum, the carotid artery
and the splenius capitis muscle in a) a representative healthy controls, and b) a representative whiplash patient.
doi:10.1371/journal.pone.0019182.g003
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these purposes. A large subset of patients with chronic pain after a
whiplash injury displayed elevated DDE retention, suggestive of
persistent peripheral tissue inflammation. The possibility to
visualize and quantify sites of inflammation in chronic pain may
be very useful in diagnosis and treatment monitoring. Inflamma-
tion imaging may also guide in examining and specifying
mechanisms in debilitating chronic pain.
Supporting Information
Figure S1 Patient A, B and C scanned in both the
Siemens HR+ PET (top row) and the GE Discovery PET-
CT (bottom row). Data is expressed as SUV values normalized
for bodyweight and injected dose.
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